Novartis Aktie
99,56
EUR
-0,84
EUR
-0,84
%
93,38
CHF
+0,42
CHF
+0,45
%
Werbung
Novartis Aktie Analyse
| 12.04.18 | Novartis Hold | Deutsche Bank AG | |
| 11.04.18 | Novartis buy | HSBC | |
| 11.04.18 | Novartis Underweight | Barclays Capital | |
| 10.04.18 | Novartis Underperform | Credit Suisse Group | |
| 10.04.18 | Novartis Hold | Deutsche Bank AG | |
| 09.04.18 | Novartis buy | S&P Capital IQ | |
| 09.04.18 | Novartis Outperform | Bernstein Research | |
| 09.04.18 | Novartis Halten | Independent Research GmbH | |
|
Werbung
|
|||
| 09.04.18 | Novartis Neutral | UBS AG | |
| 09.04.18 | Novartis Neutral | JP Morgan Chase & Co. | |
| 09.04.18 | Novartis buy | Baader Bank | |
| 28.03.18 | Novartis buy | Oddo Seydler Bank AG | |
| 28.03.18 | Novartis Hold | Deutsche Bank AG | |
| 27.03.18 | Novartis buy | S&P Capital IQ | |
| 27.03.18 | Novartis buy | Baader Bank | |
| 27.03.18 | Novartis Neutral | UBS AG | |
| 14.03.18 | Novartis buy | Société Générale Group S.A. (SG) | |
| 02.03.18 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 01.03.18 | Novartis Neutral | UBS AG | |
| 26.02.18 | Novartis buy | Jefferies & Company Inc. | |
| 21.02.18 | Novartis buy | Société Générale Group S.A. (SG) | |
| 20.02.18 | Novartis Underweight | Barclays Capital | |
| 16.02.18 | Novartis buy | Baader Bank | |
| 09.02.18 | Novartis buy | Kepler Cheuvreux | |
| 26.01.18 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 25.01.18 | Novartis overweight | Morgan Stanley | |
| 25.01.18 | Novartis Hold | Deutsche Bank AG | |
| 25.01.18 | Novartis Hold | S&P Capital IQ | |
| 25.01.18 | Novartis Underweight | Barclays Capital | |
| 25.01.18 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 24.01.18 | Novartis Neutral | Credit Suisse Group | |
| 24.01.18 | Novartis Underperform | Credit Suisse Group | |
| 24.01.18 | Novartis buy | Kepler Cheuvreux | |
| 24.01.18 | Novartis Outperform | Bernstein Research | |
| 23.01.18 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 19.01.18 | Novartis overweight | Morgan Stanley | |
| 18.01.18 | Novartis Neutral | JP Morgan Chase & Co. | |
| 15.01.18 | Novartis Neutral | UBS AG | |
| 15.01.18 | Novartis Hold | Deutsche Bank AG | |
| 10.01.18 | Novartis Neutral | JP Morgan Chase & Co. | |
| 29.12.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 27.12.17 | Novartis Halten | Norddeutsche Landesbank (Nord/LB) | |
| 06.12.17 | Novartis Underperform | Merrill Lynch & Co., Inc. | |
| 01.12.17 | Novartis overweight | Morgan Stanley | |
| 14.11.17 | Novartis overweight | Morgan Stanley | |
| 08.11.17 | Novartis Hold | Deutsche Bank AG | |
| 02.11.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 31.10.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 31.10.17 | Novartis buy | HSBC | |
| 31.10.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
Werbung
Werbung